Beschreibung:
<jats:p>Recurrence After RF Ablation of AP. <jats:italic>Introduction:</jats:italic> Many issues regarding the recurrence of accessory pathway conduction and the long‐term outcome of late block of accessory pathway conduction are still unknown or controversial.</jats:p><jats:p> <jats:italic>Methods and Results:</jats:italic> Data from 217 patients who underwent an initially successful radiofrequency ablation of accessory pathways and 7 patients with late block of accessory pathway conduction following an initially unsuccessful ablation were analyzed. During a mean follow‐up of 19 ± 11 months, accessory pathway conduction resumed in 21 (10%) of 217 patients following an initially successful ablation and in 6 (86%) of 7 patients with late block of accessory pathway conduction (P < 0.01). After initially successful ablations, the recurrence rates of accessory pathway conduction at 1, 3, and 6 months were 5.9%, 7.4%, and 11.3%, respectively. A late electrophysiologic study at 6 months uncovered recurrence in only 1 of 124 asymptomatic patients, but failed to detect the late recurrence in 2 patients in whom the accessory pathway conduction resumed after more than 6 months. Multivariate analysis revealed that independent predictors for recurrence of accessory pathway conduction were concealed accessory pathway, presence of transient effect of radiofrequency pulse, and more than 5 pulses required for initial cure. Accessory pathway location, length of the tip electrode of the ablation catheter, and repeat radiofrequency pulses (“safety pulses”) after effective pulses did not predict resumption of accessory pathway conduction.</jats:p><jats:p> <jats:italic>Conclusions:</jats:italic> After initially successful ablation, the recurrence rates of accessory pathway conduction at 1, 3, and 6 months were 5.9%, 7.4%, and 11.3%, respectively. Late electrophysiologic testing had little prognostic value in asymptomatic patients following successful ablation. Application of “safety pulses” did not prevent recurrence. Late block of accessory pathway conduction did not predict long‐term efficacy.</jats:p>